'Real-world' effectiveness of smoking cessation treatments: A population study

Addiction

Volumn 109, Issue 3, 2014, Pages 491-499

  Kotz, Daniel ^a,b   Brown, Jamie ^b   West, Robert ^b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Behavioural support; Bupropion; National household survey; Nicotine replacement therapy; Smoking cessation; Varenicline

Indexed keywords

AMFEBUTAMONE; BENZAZEPINE DERIVATIVE; DOPAMINE UPTAKE INHIBITOR; NICOTINE GUM; NICOTINIC AGENT; QUINOXALINE DERIVATIVE; VARENICLINE;

ADULT; BEHAVIOR THERAPY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; PROCEDURES; SMOKING; SMOKING CESSATION; THERAPY; TREATMENT OUTCOME; UNITED KINGDOM; YOUNG ADULT;

ADULT; BEHAVIOR THERAPY; BENZAZEPINES; BUPROPION; CROSS-SECTIONAL STUDIES; DOPAMINE UPTAKE INHIBITORS; ENGLAND; FEMALE; HUMANS; MALE; MIDDLE AGED; NICOTINIC AGONISTS; QUINOXALINES; SMOKING; SMOKING CESSATION; TOBACCO USE CESSATION PRODUCTS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84893833166     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.12429     Document Type: Article

References (44)

1. World Health Organization (WHO). WHO Report on the Global Tobacco Epidemic. Warning about the Dangers of Tobacco. Geneva: WHO; 2011.
2. Doll R., Peto R., Boreham J., Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 2004; 328: 1519.
3. Lancaster T., Stead Lindsay F. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev 2005; (2): CD001292.
4. Stead L., Bergson G., Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev 2008; (2): CD000165.
5. Stead L. F., Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev 2005; (2): CD001007.
6. Stead L. F., Perera R., Bullen C., Mant D., Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2008; (1): CD000146.
7. Hughes J. R., Stead L. F., Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev 2007; (1): CD000031.
8. Cahill K., Stead Lindsay F., Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 2012; (4): CD006103.
9. Stead Lindsay F., Lancaster T. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev 2012; (10): CD008286.
10. Raw M. Framework Convention on Tobacco Control (FCTC) Article 14 guidelines: a new era for tobacco dependence treatment. Addiction 2011; 106: 2055-2057.
11. World Health Organization (WHO). WHO Framework on Tobacco Control. Geneva: WHO; 2005. Available at: http://whqlibdoc.who.int/publications/2003/9241591013.pdf (accessed 6 September 2012) (Archived by WebCite® at http://www.webcitation.org/6LurDLcxD on 16 December 2013).
12. Pierce J. P., Gilpin E. A. Impact of over-the-counter sales on effectiveness of pharmaceutical aids for smoking cessation. JAMA 2002; 288: 1260-1264.
13. Lee C. W., Kahende J. Factors associated with successful smoking cessation in the United States, 2000. Am J Public Health 2007; 97: 1503-1509.
14. Hagimoto A., Nakamura M., Morita T., Masui S., Oshima A. Smoking cessation patterns and predictors of quitting smoking among the Japanese general population: a 1-year follow-up study. Addiction 2010; 105: 164-173.
15. Yang J., Hammond D., Driezen P., O'Connor R., Li Q., Yong H. etal. The use of cessation assistance among smokers from China: findings from the ITC China Survey. BMC Public Health 2011; 11: 75.
16. Borland R., Partos T. R., Cummings K. M. Systematic biases in cross-sectional community studies may underestimate the effectiveness of stop-smoking medications. Nicotine Tob Res 2012; 14: 1483-1487.
17. Shiffman S., Di Marino M. E., Sweeney C. T. Characteristics of selectors of nicotine replacement therapy. Tob Control 2005; 14: 346-355.
18. West R., Zhou X. Is nicotine replacement therapy for smoking cessation effective in the 'real world'? Findings from a prospective multinational cohort study. Thorax 2007; 62: 998-1002.
19. Hughes J. R., Peters E. N., Naud S. Effectiveness of over-the-counter nicotine replacement therapy: a qualitative review of nonrandomized trials. Nicotine Tob Res 2011; 13: 512-522.
20. Shiffman S., Brockwell S. E., Pillitteri J. L., Gitchell J. G. Use of smoking-cessation treatments in the United States. Am J Prev Med 2008; 34: 102-111.
21. Kasza K. A., Hyland A. J., Borland R., McNeill A. D., Bansal-Travers M., Fix B. V. etal. Effectiveness of stop-smoking medications: findings from the international tobacco control (ITC) four country survey. Addiction 2013; 108: 193-202.
22. Kotz D., Fidler J., West R. Factors associated with the use of aids to cessation in English smokers. Addiction 2009; 104: 1403-1410.
23. Kotz D., West R. Explaining the social gradient in smoking cessation: it's not in the trying, but in the succeeding. Tob Control 2009; 18: 43-46.
24. Brose L. S., West R., McDermott M. S., Fidler J. A., Croghan E., McEwen A. What makes for an effective stop-smoking service? Thorax 2011; 66: 924-926.
25. Brose L. S., McEwen A., West R. Does it matter who you see to help you stop smoking? Short-term quit rates across specialist Stop Smoking Practitioners in England. Addiction 2012; 107: 2029-2036.
26. Zhou X., Nonnemaker J., Sherrill B., Gilsenan A. W., Coste F., West R. Attempts to quit smoking and relapse: factors associated with success or failure from the ATTEMPT cohort study. Addict Behav 2009; 34: 365-373.
27. Borland R., Li L., Driezen P., Wilson N., Hammond D., Thompson M. E. etal. Cessation assistance reported by smokers in 15 countries participating in the International Tobacco Control (ITC) policy evaluation surveys. Addiction 2012; 107: 197-205.
28. Fidler J., Shahab L., West O., Jarvis M. J., McEwen A., Stapleton J. A. etal. 'The Smoking Toolkit Study': a national study of smoking and smoking cessation in England. BMC Public Health 2011; 11: 479.
29. The Smoking Toolkit Study. Available at: http://www.smokinginengland.info (accessed 16 April 2011) (Archived by WebCite® at http://www.webcitation.org/6LurS14b1 on 16 December 2013).
30. Wong S. L., Shields M., Leatherdale S., Malaison E., Hammond D. Assessment of validity of self-reported smoking status. Health Rep 2012; 23: 47-53.
31. West R., Zatonski W., Przewozniak K., Jarvis M. J. Can we trust national smoking prevalence figures? Discrepancies between biochemically assessed and self-reported smoking rates in three countries. Cancer Epidemiol Biomarkers Prev 2007; 16: 820-822.
32. Fidler J. A., Shahab L., West R. Strength of urges to smoke as a measure of severity of cigarette dependence: comparison with the Fagerstrom Test for Nicotine Dependence and its components. Addiction 2011; 106: 631-638.
33. Fiore M. C., Jaén C. R., Baker T. B., Bailey W. C., Benowitz N. L., Curry S. J. etal. Treating Tobacco Use and Dependence: 2008 Update. Rockville, MD: US Department of Health and Human Services; 2008.
34. Hughes J. R., Shiffman S., Callas P., Zhang J. A meta-analysis of the efficacy of over-the-counter nicotine replacement. Tob Control 2003; 12: 21-27.
35. Kouvonen A., Kivimäki M., Oksanen T., Pentti J., Heponiemi T., Väänänen A. etal. Implementation of workplace-based smoking cessation support activities and smoking cessation among employees: the Finnish Public Sector Study. Am J Public Health 2012; 102: e56-62.
36. Nonnemaker J., Hersey J., Homsi G., Busey A., Hyland A., Juster H. etal. Self-reported exposure to policy and environmental influences on smoking cessation and relapse: a 2-year longitudinal population-based study. Int J Environ Res Public Health 2011; 8: 3591-3608.
37. Boutou A. K., Tsiata E. A., Pataka A., Kontou P. K., Pitsiou G. G., Argyropoulou P. Smoking cessation in clinical practice: predictors of six-month continuous abstinence in a sample of Greek smokers. Prim Care Respir J 2008; 17: 32-38.
38. Zhu S., Melcer T., Sun J., Rosbrook B., Pierce J. P. Smoking cessation with and without assistance: a population-based analysis. Am J Prev Med 2000; 18: 305-311.
39. Taggar J., Coleman T., Lewis S., Szatkowski L. The impact of the Quality and Outcomes Framework (QOF) on the recording of smoking targets in primary care medical records: cross-sectional analyses from The Health Improvement Network (THIN) database. BMC Public Health 2012; 12: 329.
40. Lawrence D., Mitrou F., Zubrick S. R. Non-specific psychological distress, smoking status and smoking cessation: United States National Health Interview Survey 2005. BMC Public Health 2011; 11: 256.
41. Vangeli E., Stapleton J., Smit E. S., Borland R., West R. Predictors of attempts to stop smoking and their success in adult general population samples: a systematic review. Addiction 2011; 106: 2110-2121.
42. Berg C. J., An L. C., Kirch M., Guo H., Thomas J. L., Patten C. A. etal. Failure to report attempts to quit smoking. Addict Behav 2010; 35: 900-904.
43. West R., Hajek P., Stead L., Stapleton J. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction 2005; 100: 299-303.
44. Kotz D., Fidler J., West R. Very low rate and light smokers: smoking patterns and cessation-related behaviour in England, 2006-11. Addiction 2012; 107: 995-1002.